NEW YORK / Oct 08, 2025 / Business Wire / Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025.
Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows:
Live Call: 1.855.761.5600
Conference ID: 7768132
Webcast
The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following November 6, 2025 for a period of 90 days.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. Oscar has been challenging the status quo in the healthcare system since its founding in 2012, and is dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Oscar’s technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 2.0 million members, as of June 30, 2025.
Last Trade: | US$20.51 |
Daily Change: | -0.16 -0.77 |
Daily Volume: | 11,199,893 |
Market Cap: | US$4.570B |
September 15, 2025 August 06, 2025 July 22, 2025 May 07, 2025 February 04, 2025 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load